2Suppliers
0Customers
2Debt Items
20Related Chains

ImageneBio, Inc. Suppliers

TickerNameConfidenceEvidence
HUTCHMED HUTCHMED 90% Our licenses from Hutchmed and WuXi Biologics are limited to intellectual property rights owned or controlled by such licensors.
WUXI-BIOLOGICS WUXI-BIOLOGICS 90% Our licenses from Hutchmed and WuXi Biologics are limited to intellectual property rights owned or controlled by such licensors.

ImageneBio, Inc. Customers

No clients on recordNo downstream customers found in our database for ImageneBio, Inc..

ImageneBio, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
IMA-DEBT Debt stack $2.4M 90% Market cache reports total debt of $2.4M.
IMA-DEBT-10227 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.

ImageneBio, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ImageneBio, Inc..

ImageneBio, Inc. Ownership

HolderNameConfidenceEvidence
IMA-OWNER-BVF-INC-IL BVF INC/IL 90% 13F overlay lists BVF INC/IL as top holder; 38 tracked holders.

ImageneBio, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
GRDX GridAI Technologies Corp. 100.00 2